Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Hypertrophic Obstructive Cardiomyopathy Phenotype/Phenocopy

Presenter/Author Information

Zaid Abood MD, Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Muddasir Ashraf MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Asad Ghafoor MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Amanda Misicka RN, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Patrycja Galazka MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
M Fuad Jan MBBS, MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Arshad Jahangir MD, Electrophysiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
A Jamil Tajik MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow

Recommended Citation

Abood Z, Ashraf M, Ghafoor A, et al. Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Hypertrophic Obstructive Cardiomyopathy Phenotype/Phenocopy. J Patient Cent Res Rev. 2024;11:257-258. doi: 10.17294/2330-0698.2137

Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers

Presentation Notes

Case report or series poster presentation at Scientific Day; May 22, 2024; Milwaukee, WI. https://institutionalrepository.aah.org/sciday/2024/casereportvirtual/1/

Document Type

Abstract